1. Home
  2. ENVX vs SPTX Comparison

ENVX vs SPTX Comparison

Compare ENVX & SPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Enovix Corporation

ENVX

Enovix Corporation

HOLD

Current Price

$5.13

Market Cap

1.2B

Sector

Miscellaneous

ML Signal

HOLD

Logo Seaport Therapeutics Inc. Common Stock

SPTX

Seaport Therapeutics Inc. Common Stock

N/A

Current Price

$20.62

Market Cap

1.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ENVX
SPTX
Founded
2006
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.1B
IPO Year
2020
2026

Fundamental Metrics

Financial Performance
Metric
ENVX
SPTX
Price
$5.13
$20.62
Analyst Decision
Buy
Analyst Count
9
0
Target Price
$13.61
N/A
AVG Volume (30 Days)
5.3M
179.3K
Earning Date
05-13-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
40.94
N/A
EPS
N/A
N/A
Revenue
$31,821,000.00
N/A
Revenue This Year
$30.37
N/A
Revenue Next Year
$238.73
N/A
P/E Ratio
N/A
N/A
Revenue Growth
37.91
N/A
52 Week Low
$4.67
$17.59
52 Week High
$16.49
$22.98

Technical Indicators

Market Signals
Indicator
ENVX
SPTX
Relative Strength Index (RSI) 37.82 57.45
Support Level $4.75 $17.89
Resistance Level $5.56 $22.36
Average True Range (ATR) 0.38 1.98
MACD -0.06 -0.04
Stochastic Oscillator 18.52 49.36

Price Performance

Historical Comparison
ENVX
SPTX

About ENVX Enovix Corporation

Enovix Corp is engaged in designing, developing, manufacturing, and commercializing Lithium-ion, or Li-ion, battery cells. It uses BreakFlow and Encapsulation technologies to manufacture high capacity and resilient batteries. The company's product portfolio comprises power disc batteries, flexible lithium-ion polymer batteries, superior lithium-ion polymer batteries, active silicon lithium-ion cells, and others. Geographically, the company generates maximum revenue from its customers in South Korea, followed by Switzerland, the United States, Norway, Taiwan, and other regions.

About SPTX Seaport Therapeutics Inc. Common Stock

Seaport Therapeutics Inc is a clinical-stage therapeutics company. The company focuses on invention and development of new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders. The company identified clinically validated mechanisms with established efficacy and safety profiles, historically limited by high first-pass metabolism, low bioavailability, and side effects. The company's pipeline products are based on Glyph, company's lymphatic-targeting prodrug technology is designed to bypass first-pass metabolism and thereby enhance a drug's oral bioavailability and reduce side effects.

Share on Social Networks: